[APVO] YoY Quarter Result on 30-Sep-2018 [#Q3]

Stock
[APVO] Aptevo Therapeutics Inc.
Announcement Date
14-Nov-2018
Financial Year
2018
Quarter
30-Sep-2018 [#Q3]
Profit Trend
QoQ- 4.43%
YoY- -133.17%
Quarter Report
APVO's Result
APVO's Financial Summary
View:
Show?
Quarter Result
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
Revenue 3,096 1,463 9,011 5,824 6,172 9,405 6,562 -11.75%
PBT -7,077 -6,948 -11,174 -12,601 -10,784 -71,747 -13,104 -9.74%
Tax -80 -157 -999 -39 -13,768 -6 -424 -24.24%
NP -6,997 -6,791 -6,924 -12,562 37,867 -71,741 -12,680 -9.42%
Tax Rate - - - - - - - -
Total Cost 10,093 8,254 15,935 18,386 -31,695 81,146 19,242 -10.18%
Ratio Analysis
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
NP Margin -226.00 -464.18 -76.84 -215.69 613.53 -762.80 -193.23 2.64%
Per Share
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
EPS -63.08 -92.43 -94.43 -341.30 85.95 -2,185.29 -386.10 -26.04%
EPS Diluted -62.93 -92.43 -94.43 -341.30 85.95 -2,183.83 -386.10 -26.07%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.